Walleye Capital LLC Century Therapeutics, Inc. Transaction History

Walleye Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$4.84 - $11.58 $126,967 - $303,778	26,233 Added 20.73%	152,796 $783,000
Q3 2022 Nov 14, 2022	BUY	$8.57 - $13.1 $410,203 - $627,031	47,865 Added 60.82%	126,563 $1.25 Million
Q2 2022 Aug 08, 2022	BUY	$7.96 - $12.43 $221,208 - $345,429	27,790 Added 54.59%	78,698 $661,000
Q1 2022 May 16, 2022	SELL	$11.62 - $15.92 $134,362 - $184,082	-11,563 Reduced 18.51%	50,908 $641,000
Q4 2021 Mar 03, 2022	BUY	$13.93 - $23.62 $870,221 - $1.48 Million	62,471 New	62,471 $990,000

36.9M

8.7K

10.2K

Ticker IPSC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,881,800
Market Cap $74.2M
Description
Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 fo...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.